ANTICOAGULANT
Savaysa (edoxaban) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and blood clots that travel to other parts of the body in people with nonvalvular atrial fibrillation (NVAF), a type of irregular heartbeat.
Savaysa is a blood thinner called a factor Xa inhibitor. It blocks factor Xa, a protein that helps blood clot. This reduces the production of thrombin, another protein involved in clotting, and helps prevent blood clots from forming.
Doctors prescribe Savaysa when:
Savaysa is taken by mouth, with or without food. If you have trouble swallowing tablets, talk to your healthcare provider about other ways to take Savaysa.
Creatinine clearance is a measure of how well the kidneys filter waste from the blood.
This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.
This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.
In clinical studies of Savaysa, the most common side effects occurred in about 2 percent to 26 percent of people. These included:
Savaysa has a boxed warning, the FDA’s strongest safety warning, for some of the serious risks described below. A boxed warning does not mean the drug is unsafe for everyone or that everyone faces the same level of risk.
Savaysa can cause serious side effects that may require immediate medical attention. These include:
Get medical help right away if you think you are having a serious reaction.
This drug has a boxed warning, the FDA's strongest safety warning, for some of the serious risks mentioned above. A boxed warning does not mean the drug is unsafe for everyone or that everyone faces the same level of risk.
If you experience serious side effects, you can report them to the FDA online or by calling 1-800-FDA-1088. You can also contact the drug's manufacturer.
Daiichi Sankyo, the manufacturer of Savaysa, offers the SAVAYSA Savings Card. Eligible people with commercial or employer-sponsored insurance may qualify for copay assistance and pay as little as $4 per month, depending on eligibility and program terms.
To learn more, visit the Savaysa savings page.
Before starting Savaysa for nonvalvular atrial fibrillation, your doctor will check your kidney function using a test called creatinine clearance.
Before taking Savaysa, tell your doctor if you have any allergies to edoxaban or any ingredients in Savaysa.
Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
Also tell your doctor if you:
Do not take Savaysa if you have active abnormal bleeding. Savaysa can increase the risk of serious bleeding.
If you miss a dose, take it as soon as you remember on the same day. Take your next dose at the usual time the following day. Do not take two doses at the same time to make up for a missed dose.
If you are pregnant or planning to become pregnant while taking Savaysa, talk with your doctor about the risks and benefits. It is not known whether Savaysa can harm a developing baby. Tell your doctor right away if you become pregnant during treatment.
If you can become pregnant, discuss pregnancy planning and the risk of severe uterine bleeding with your doctor.
If you are breastfeeding or planning to breastfeed, talk with your doctor before taking Savaysa. Do not breastfeed while taking Savaysa. It is not known whether Savaysa passes into breast milk.
These answers are fact-checked by our editorial staff.
How effective is Savaysa for heart conditions?
In a large clinical study, Savaysa was compared with warfarin, another blood thinner, in people with nonvalvular atrial fibrillation. Among people whose creatinine clearance was 95 milliliters per minute or less:
These results were from the Savaysa 60-milligram treatment group, including people whose dose was reduced to 30 milligrams when needed. Savaysa should not be used to reduce stroke risk in people with NVAF whose creatinine clearance is greater than 95 milliliters per minute because they had a higher risk of ischemic stroke than those taking warfarin.
How long does Savaysa take to work for heart conditions?
Savaysa begins affecting blood clotting after it is taken by mouth. Its strongest effects on blood clotting and highest blood levels are generally reached within one to two hours. With once-daily dosing, Savaysa reaches steady blood levels within three days.
These findings describe how quickly Savaysa acts in the body. They do not establish an exact time when protection against stroke begins.
Does Savaysa interact with other medicines?
Yes. Savaysa can interact with certain medicines, which may increase your risk of bleeding or affect how well Savaysa works. These include:
Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements you take. Do not start or stop any medicines without talking to your healthcare provider.
On MyHeartDiseaseTeam, people share their experiences with heart disease, get advice, and find support from others who understand.
Learn more about Savaysa and heart disease care:
More resources from MyHeartDiseaseTeam that mention Savaysa
Become a member to get even more